Related Experiment Video
Updated: Sep 15, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Cancer-Related Alopecia Risk and Treatment.
Lily Kaufman1, Lilia Valentic1, Hannah Moulton1
1The Ohio State University College of Medicine, Columbus, OH, USA.
Managing cancer-related alopecia (CRA) involves proactive strategies like scalp cooling for chemotherapy patients to prevent hair loss. Topical minoxidil is recommended for promoting hair regrowth, with other options available for specific cases.
Area of Science:
- Oncology
- Dermatology
- Patient Care
Background:
- Cancer-related alopecia (CRA) significantly impacts patient quality of life and identity.
- Effective management strategies for CRA are crucial for patient well-being during cancer treatment.
Purpose of the Study:
- To outline an optimal, personalized approach for managing cancer-related alopecia.
- To review evidence-based strategies for both preventing and promoting hair regrowth in cancer patients.
Main Methods:
- Literature review and expert opinion on current CRA management practices.
- Evaluation of preventative measures like scalp cooling.
- Assessment of pharmacologic and non-pharmacologic treatments for hair regrowth.
Main Results:
- Scalp cooling is recommended as a first-line preventative option for chemotherapy-induced alopecia.
- Topical minoxidil is the most evidence-based pharmacologic treatment for promoting hair regrowth.
- Other therapies like spironolactone, tretinoin, and red light therapy may be considered with caution due to limited evidence.
Conclusions:
- A proactive, patient-centered, and multidisciplinary approach is essential for optimal CRA management.
- Integrating preventative and regrowth strategies tailored to individual patient needs and cancer therapy is key.
- Continued research is needed for emerging treatments like oral minoxidil in oncology settings.
More Related Videos
03:22Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Cancer Survival Analysis
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...